To elucidate the mechanism by which OTSSP167 inhibits the proliferation of GBM cells, western blotting was performed to evaluate the effect of OTSSP167 on the expression of MELK, AKT, and downstream signaling pathway proteins in GBM cells. Here, AKT1 is linked to glioblastoma.